Login to Your Account

Telik Begins Registration Study Of TLK286 In Ovarian Cancer

By Aaron Lorenzo

Friday, March 28, 2003
Plans to push its lead compound into a Phase III trial has Telik Inc. beaming like a proud parent at a child's graduation. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription